search
High-throughput experimentation (HTE) empowers drug developers to quickly build robust platforms for scale-up. Facing constraints on their time, resources, and materials, companies leverage this approach to rapidly execute many miniaturized reactions in parallel to survey a wide range of possible reaction conditions.
CDMOs are defined by project execution and delivery. Clients and patients alike need service providers to complete projects as quickly and efficiently as possible, adapting nimbly to unforeseen developments to consistently come in on time and on budget.
Lyophilization is a vital process employed to enhance the stability and extend the shelf life of drug products particularly Biologics and other complex modalities.
Cryogenic reactions are essential for synthesizing some active pharmaceutical ingredients (APIs). By working in cryogenic conditions, chemists can reduce impurities, ensure safety, improve selectivity, and facilitate reactions that are impossible at higher temperatures.
Highly Potent Active Pharmaceutical Ingredients (HPAPIs) continue to be a rapidly growing segment of the pharmaceutical industry.
